Aprea Therapeutics, Inc. (APRE)

Free Cash Flow

-$12.18M

TTM · Period ending: · USD

APRE logo

APRE Free Cash Flow

Latest reported-$12.18M
APRE TTM Free Cash Flow (-$26.67M → -$12.18M)
High-resolution chart · PNG

APRE free cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aprea Therapeutics, Inc. Free Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFree Cash Flow (USD)
-12,183,411
-12,020,002
-12,894,439
-13,444,051
-12,741,123
-13,259,490
-13,572,196
-13,808,100
-13,667,706
-13,235,489
-12,270,701
-12,544,405
-16,809,179
-22,494,888
-25,011,136
-31,169,411
-32,810,133
-31,659,403
-37,686,180
-40,722,885
-45,647,451
-47,531,860
-43,563,544
-40,791,832
-34,057,074
-30,027,068
-26,670,624
-20,077,309
-16,806,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.